Skip to main content

Time to make a difference for cancer patients – the impact of nutritional care

A growing body of evidence demonstrates the benefits of medical nutrition in optimizing health and therapeutic outcomes for patients, as well as helping to reduce the length of hospital stays. Data shows that the combination of drug therapies with tailored nutritional care effectively supports improved patient outcomes, especially in the field of cancer management. The benefits of integrating a targeted medical nutrition solution into a multimodal therapeutic care plan, presents a game-change!

The panel will discuss why nutritional management should be integrated to standard drug therapies, and how disease-specific medical nutrition formulations can enable holistic cancer therapies to take hold.

The objective of this event is to bring together experts, to build up well-informed perspectives about the benefits of a multimodal therapeutic approach in cancer treatment.

The session will be hosted by Patricia Malarkey, Chief Innovation Officer and member of the Executive Committee at DSM, and bring together leading scientists and industry experts from across the field:

  • Helen Banks, Senior Researcher in the Health Economics and Health Technology Assessment Area, SDA Bocconi School of Management, Milan, Italy
  • Alessandro Laviano, MD, Associate Professor of Internal Medicine, Department of Clinical Medicine, Sapienza University, Rome, Italy
  • Andreas Busch, Business Executive Officer, Nestlé Health Science, Switzerland
  • Barbara Troesch, Senior Scientific Affairs Manager, Global Pharmaceutics and Medical Nutrition, DSM
Helen Banks
Barbara Troesch
Andreas Busch
Alessandro Laviano

Register now to the live broadcast.

Hosted by:

 25 May 2022, Wednesday  07:00-08:30

This event has finished already. Watch live
Our partners

Join the conversation